Interestingly, stimulation through TLR-3, -4, and -7 has previously been reported to synergize with CD47 blockade on tumor cells by increasing secretion and cell-surface exposure of calreticulin on macrophages in a Btk-dependent manner [23]. Here, TLR3 is linked to neoplasm.